Glycosaminoglycan replacement 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cystistat (sodium hyaluronate) / Viatris
ChiCTR-TRC-10000788: A Clinical multi-center, randomized, open-label, blank control trial of Cystistat in combination with THP by co-perfusion to reduce complications induced by THP-chemotherapy

Completed
4
120
 
30mg THP diluted with 50ml water for injection, after routine disinfection, place catheters in the bladder and empty the bladder, then give THP perfusion, by injecting a small amount of air to prevent THP residues, then remove the catheter, Make patients to change their positions every 8 minutes, and 32 minutes later make THP discharged from the bladder ;30mg THP diluted with 50ml water for injection. After routine disinfection, place catheters in the bladder and empty the bladder then give THP perfusion, by injecting a small amount of air to prevent THP residues, and then keep urethral catheter in under the condition of occlusion. Make patients to change their positions every 8 minutes. 32 minutes later, make THP discharged from the catheter and empty the bladder, then give Cystistat perfusion instantly (40mg/50ml/ bottle for each perfuse
Tongji Hospital of Tongji Medical college of Huazhong University of Science and Technology; ShenZhen Kangzhe Pharmaceutical CO., LTD, ShenZhen Kangzhe Pharmaceutical CO.,LTD
complications induced by THP instillation/non-muscle invasive tumor
 
 
IC/BPS, NCT05544695: Real-world Evidence Study on Cystistat

Active, not recruiting
N/A
74
Europe
intravesical sodium hyaluronate (Cystistat®)
MEDA Pharma GmbH & Co. KG
Interstitial Cystitis and Bladder Pain Syndrome
01/25
03/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cystistat (sodium hyaluronate) / Viatris
ChiCTR-TRC-10000788: A Clinical multi-center, randomized, open-label, blank control trial of Cystistat in combination with THP by co-perfusion to reduce complications induced by THP-chemotherapy

Completed
4
120
 
30mg THP diluted with 50ml water for injection, after routine disinfection, place catheters in the bladder and empty the bladder, then give THP perfusion, by injecting a small amount of air to prevent THP residues, then remove the catheter, Make patients to change their positions every 8 minutes, and 32 minutes later make THP discharged from the bladder ;30mg THP diluted with 50ml water for injection. After routine disinfection, place catheters in the bladder and empty the bladder then give THP perfusion, by injecting a small amount of air to prevent THP residues, and then keep urethral catheter in under the condition of occlusion. Make patients to change their positions every 8 minutes. 32 minutes later, make THP discharged from the catheter and empty the bladder, then give Cystistat perfusion instantly (40mg/50ml/ bottle for each perfuse
Tongji Hospital of Tongji Medical college of Huazhong University of Science and Technology; ShenZhen Kangzhe Pharmaceutical CO., LTD, ShenZhen Kangzhe Pharmaceutical CO.,LTD
complications induced by THP instillation/non-muscle invasive tumor
 
 
IC/BPS, NCT05544695: Real-world Evidence Study on Cystistat

Active, not recruiting
N/A
74
Europe
intravesical sodium hyaluronate (Cystistat®)
MEDA Pharma GmbH & Co. KG
Interstitial Cystitis and Bladder Pain Syndrome
01/25
03/25

Download Options